ConductScience.org, home

Gene · 5132

PDC: phosducin

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. PDC: phosducin. Genes, record 5132. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5132

On this page

Gene

Symbol
PDC
HGNC
Name
phosducin
HGNC
NCBI Gene ID
5132
NCBI Gene
HGNC ID
HGNC:8759
HGNC
Ensembl
ENSG00000116703
NCBI Gene
Aliases
MEKA, PHD, PhLOP, PhLP
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P20941Phosducin2460Ensembl, GeneID, HGNC

Source UniProt

Patents18

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1457554P20941Espacenet
JP 2026004568 A2026-01-1457555P20941Espacenet
JP 2025032204 A2025-03-1133130P20941Espacenet
EP 4461818 A22024-11-1333130P20941Espacenet
JP 2023058610 A2023-04-2533130P20941Espacenet
US 11446398 B22022-09-2062404P20941Espacenet
JP 2022524081 A2022-04-27165375P20941Espacenet
JP 2020508652 A2020-03-2633130P20941Espacenet
JP 2019054813 A2019-04-11237989P20941Espacenet
JP 2019054813 A2019-04-11237990P20941Espacenet

1 to 10 of 18

See all 18 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants904

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitlePDC papersNewest fiscal year
P01CA155258Integrative Oncogenomics of Multiple Myeloma62025
P30CA008748Cancer Center Support Grant52025
T32AI100853Training Program in Immunology and Inflammation52025
P30EY005722Center Core Grant for Vision Research42025
R37AI072571Molecular Control of Plasmacytoid Dendritic Cell Development and Function42025
P30CA016672Cancer Center Support Grant32025
R01AI077653Antigenic determinants of asthma-associated allergens for design of immunotherapy32025
UL1TR001866Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success32025
ZIAAI001155Mechanisms of naturally-acquired immunity to malaria and clinical trials of anti-malaria monoclonal antibodies32025
K24AR076975Linking Disease Mechanisms and Outcomes in Rheumatic Diseases22025

1 to 10 of 904Source NIH's project files

See all 904 nih grants

Papers1,377

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Advances of Peptide-Drug Conjugates in the Treatment of Digestive System Tumors.Drug Des Devel Ther202642802838PubTator, text miningPubMed
Peptide-drug conjugates in breast cancer therapy: Emerging targets, translational challenges, and optimization strategies.J Pharmacol Exp Ther202642790198PubTator, text miningPubMed
Stress-driven reprogramming of plasmacytoid dendritic cells in intrahepatic cholangiocarcinoma defines a reversible targetable immunosuppressive state.World J Surg Oncol202642760567PubTator, text miningPubMed
Priming Cells with Modulators of Cellular Signaling Ensures Enhanced Selectivity of HSPG-Specific Protein-Drug Conjugate Delivery.J Am Chem Soc202642714551PubTator, text miningPubMed
Irradiation-Induced CD62L Shedding in Human Plasmacytoid Dendritic Cells Depends on ADAM17 and p38 MAPK.Immunology202642686427PubTator, text miningPubMed
Engineering peptide-drug conjugates for targeted cancer therapy: design principle, theranostic imaging, and translational challenges.Adv Drug Deliv Rev202642674319PubTator, text miningPubMed
Integrated Patient-Derived Xenograft and Patient-Derived Cell Models Reveal Therapeutic Vulnerabilities Beyond Standard-of-Care Therapy in Endometrial Cancer.bioRxiv202642619684PubTator, text miningPubMed
Abexinostat attenuates temozolomide-resistant glioma stem cells.Neuro Oncol202642616000PubTator, text miningPubMed
TPGS Analog-Mediated Intracellular ROS-Amplifying Strategy Potentiates the In Vitro Anticancer Activity of a Dual-Thioketal-Linked Polymeric Drug Conjugate in A549 Lung Cancer Cells.Pharmaceutics202642514963PubTator, text miningPubMed
Acetyl-CoA metabolism in skeletal biology and bone disorders: From mechanisms to therapeutic implications.Pharmacol Res202642468581PubTator, text miningPubMed

1 to 10 of 1,377

See all 1,377 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/5132

GET https://conductscience.org/api/genes/v1/5132/patents